Immunoassay Reagent Alinity i CA 19-9XR CLIA Non-Waived For Alinity i System 200 Tests

Features

• The Alinity i CA 19-9XR assay is a chemiluminescent microparticle immunoassay (CMIA) used for the quantitative determination of 1116-NS-19-9 reactive determinants in human serum or plasma on the Alinity i analyzer
• The Alinity i CA 19-9XR assay is to be used as an aid in the management of pancreatic cancer patients with detectable levels of CA 19-9 at some point in their disease process and in conjunction with other clinical methods

More Information

• SDS